Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...

Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

Investors with a lot of money to spend have taken a bullish stance on Eli Lilly LLY. And retail traders should know. We ...

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

More than 110,000 North Carolinians are projected to benefit from a $2,000 annual cap on out-of-pocket costs for covered prescription drugs for Medicare Part D participants.

The Centers for Medicare and Medicaid Services announced Friday that 64 Part B drugs will have a reduced price for Medicare ... 10 popular drugs like Enbrel, Jardiance and Januvia, starting ...

After years of delays and debate, 2024 was the year when several health initiatives started to move forward. And advocates ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Shares of Eli Lilly and Company (NYSE:LLY – Get Free Report) dropped 0.6% on Tuesday . The company traded as low as $767.25 and last traded at $768.83. Approximately 348,052 shares traded hands during ...

Eli Lilly and Company (NYSE:LLY – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the ...

Under the IRA, companies that refuse to reduce prices risk an excise tax starting ... became clear that its big-selling diabetes treatment Jardiance (empagliflozin) – sold with Eli Lilly ...